Influenza and respiratory syncytial virus. Update on infection, management, and prevention.
This article is an overview of the epidemiology and spectrum of clinical disease attributed to influenza and respiratory syncytial virus in children. It separately discusses the pathogenesis of the two diseases and the host responses to the viruses to emphasize each infection's significance and need for a vaccine. Updates on current preventive measures and a preview of potential future vaccine developments are presented.
Malhotra
A
A
Division of Pediatric Infectious Disease, North Shore University Hospital-New York University School of Medicine, Manhasset, USA.
Krilov
L R
LR
D000276:Adjuvants, Immunologic; D002648:Child; D006801:Humans; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D018357:Respiratory Syncytial Virus Infections / Q000453:epidemiology / Q000517:prevention & control; D012136:Respiratory Syncytial Viruses / Q000276:immunology; D014613:Vaccines, Attenuated; D014764:Viral Proteins; D014765:Viral Vaccines
D000276:Adjuvants, Immunologic; D007252:Influenza Vaccines; D014613:Vaccines, Attenuated; D014764:Viral Proteins; D014765:Viral Vaccines